Integration of single‐cell and bulk RNA ‐sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model
Cancer Reports · 2024
DOI: 10.1002/cnr2.1935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2024. Verfasst von Yaping Mu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The School of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Clinical Research on the Prevention and Treatment of Primary Liver Cancer Based on the Academic Thought of Professor Sun Tongjiao, a National Famous Trad….
Abstract (Originalsprache)
Background
The highly heterogeneous nature of hepatocellular carcinoma (HCC) results in different responses and prognoses to the same treatment in patients with similar clinical stages.
Aims
Thus, it is imperative to investigate the association between HCC tumor heterogeneity and treatment response and prognosis. Methods and Results At first, we downloaded scRNA‐seq, bulk RNA‐seq, and clinical data from TCGA and GEO databases. We conducted quality control, normalization using SCTransform, dimensionality reduction using PCA, batch effect removal using Harmony, dimensionality reduction using UMAP, and cell annotation‐based marker genes on the scRNA‐seq data. We recognized tumor cells, identified tumor‐related genes (TRGs), and performed cell communication analysis. Next, we developed a prognostic model using univariable Cox, LASSO, and multivariate Cox analyses. The signature was evaluated using survival analysis, ROC curves, C‐index, and nomogram. Last, we studied the predictability of the signature in terms of prognosis and immunotherapeutic response for HCC, assessed a variety of drugs for clinical treatment, and used the qRT‐PCR analysis to validate the mRNA expression levels of prognostic TRGs.
Conclusion
To conclude, this study expounded upon the influence of tumor cell heterogeneity on the prediction of treatment outcomes and prognosis in HCC. This, in turn, enhances the predictive ability of the TNM staging system and furnishes novel perspectives on the prognostic assessment and therapy of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The School of Integrated Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan, China.
- Department of Hepatobiliary, The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.
- School of Traditional Chinese Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China.
ORCID-Profile: Jing Wang
Förderung
- Basic Clinical Research on the Prevention and Treatment of Primary Liver Cancer Based on the Academic Thought of Professor Sun Tongjiao, a National Famous Trad…
Zitieren
APA
Mu, Y., Zheng, D., Peng, Q., Wang, X., Zhang, Y., Yin, Y., Wang, E., Ye, F., & Wang, J. (2024). Integration of single‐cell and bulk RNA ‐sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model. Cancer Reports. https://doi.org/10.1002/cnr2.1935
Vancouver
Mu Y, Zheng D, Peng Q, Wang X, Zhang Y, Yin Y, et al. Integration of single‐cell and bulk RNA ‐sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model. Cancer Reports. 2024. doi:10.1002/cnr2.1935
BibTeX
@article{Mu2024,
author = {Mu, Yaping and Zheng, Ding and Peng, Qinghua and Wang, Xiaodong and Zhang, Yurong and Yin, Yue and Wang, Encheng and Ye, Fei and Wang, Jing},
title = {Integration of single‐cell and bulk RNA ‐sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.1935}
}
EUVIMED